Abstract
Most studies examining HIV antiretroviral medication treatment adherence involve quantitative surveys. Although these studies have identified factors associated with medical adherence, no single variable or combination of variables is sufficiently consistent to apply to any individual or group of people. Using qualitative methods, an ethnically diverse sample (N = 110) of HIV+ women, men who have sex with men, and male injecting drug users in four U.S. cities were interviewed in depth to elicit their experiences, perspectives, and life contexts regarding knowledge, attitudes, beliefs, and experiences with HIV medication adherence. Most described multiple influences on medication-taking behavior, describing adherence as a dynamic phenomenon that changes over time with their changing beliefs, attitudes, emotions, and daily and larger life events. Prevalent themes include ambivalence toward HIV medication and intentional nonadherence, usually to address physical side effects. Factors from different domains (e.g., cognitive, emotional, interpersonal) can have compensatory influences on behavioral outcomes. Findings are discussed in terms of social action theory, contributing to our theoretical understanding of the phenomenon of adherence.
Similar content being viewed by others
References
Alonzo, A. A., and Reynolds, N. R. (1995). Stigma, HIV and AIDS: An exploration and elaboration of a stigma trajectory. Social Science and Medicine, 41, 303-315.
Bartos, M., and McDonald, K. (2000). HIV as identity, experience or career. AIDS Care, 12, 299-306.
Bogart, L. M., Catz, S. L., Kelly, J. A., Gray-Bernhardt, M. L., Hartmann, B. R., Otto-Salaj, L. L., Hackl, K. R., and Bloom, F. R. (2000). Psychosocial issues in the era of new AIDS treatments from the perspective of persons living with HIV. Journal of Health Psychology, 5, 500-516.
Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., and McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124-133.
Chesney, M. A. (2000). Factors affecting adherence to antiretroviral therapy. Clinical Infectious Diseases, 30, S171-S176.
Chesney, M. A., and Smith, A. W. (1999). Critical delays in HIV testing and care: The potential role of stigma. American Behavioral Scientist, 42, 1162-1174.
Chesney, M. A., Ickovics, J., Hecht, F. M., Sikipa, G., and Rabkin, J. (1999). Adherence: A necessity for successful HIV combination therapy. AIDS, 13(Supplement A), S271-S278.
Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., and Wu, A. W. (2000a). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12, 255-266.
Chesney, M. A., Morin, M., and Sherr, L. (2000b). Adherence to HIV combination therapy. Social Science and Medicine, 50, 1599-1605.
Crespo-Fierro, M. (1997). Compliance/adherence and care management in HIV disease. Journal of the Association of Nurses in AIDS Care, 8, 43-54.
David, E. (1999). HAART attack: Metabolic disorders during long-term antiretroviral therapy. BETA, 12, 10-14.
Dunbar-Jacob, J., and Sereika, S. (2001). Conceptual and methodological problems. In E. Lora, E. Burke, E. Ira, and S. Ockene (Eds.), Compliance in healthcare and research (pp. 93-104). Armonk, NY: Futura.
Ewart, C. K. (1991). Social action theory for a public health psychology. American Psychologist, 46, 931-946.
Gordillo, V., del Amo, J., Soriano, V., and Gonzalez-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763-1769.
Hecht, F. M., Colfax, G., Swanson, M., and Chesney, M. A. (1998). Adherence and effectiveness of protease inhibitors in clinical practice. In Program and abstracts of the Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, Il (Abstract #151/Session 24). Available at http://www.retroconference.org; accessed July 21, 2001.
Horne, R. (2000, November). Take HAART?: Self-regulation and adherence to highly active anti-retroviral therapy (HAART). Paper presented at the Integrating Psychology and Medicine Conference, Auckland, New Zealand.
Kalichman, S. C., Ramachandran, B., and Catz, S. (1999). Adherence to combination antiretroviral therapies in HIV patients of low health literacy. Journal of General Internal Medicine, 14, 267-273.
Kastrissios, H., Suárez, J. R., Hammer, S., Katzenstein, D., and Blaschke, T. F. (1998). The extent of non-adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker. AIDS, 12, 2305-2311.
Kelly, J. A., Murphy, D. A., Bahr, G. R., Koob, J. J., Morgan, M. G., Kalichman, S. C., Stevenson, L. Y., Brasfield, T. L., Bernstein, B. M., and St. Lawrence, J. S. (1993). Factors associated with severity of depression and high-risk sexual behavior among persons diagnosed with human immunodeficiency virus (HIV) infection. Health Psychology, 12, 215-219.
Leigh, B. C., and Stall, R. (1993). Substance use and risky sexual behavior for exposure to HIV: Issues in methodology, interpretation, and prevention. American Psychologist, 48, 1035-1045.
Malow, R. M., Baker, S. M., Klimas, N., Antoni, M. H., Schneiderman, N., Penedo, F. J., Ziskind, D., Page, B., McMahon, R., and McPherson, S. (1998). Adherence to complex combination antiretroviral therapies by HIV-positive drug abusers. Psychiatric Services, 49, 1021-1022.
Molaghan, J. B. (1997). Adherence issues in HIV therapeutics. Introduction: The situation. Journal of the Association of Nurses in AIDS Care, 8, 7-9.
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., and Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
Patton, M. Q. (1990). Humanistic psychology and humanistic research. Person-Centered Review, 5, 191-202.
Proctor, V. E., Tesfa, A., and Tompkins, D. C. (1999). Barriers to adherence to highly active antiretroviral therapy as expressed by people living with HIV/AIDS. AIDS Patient Care and STDs, 13, 535-544.
Pryor, J. B., Reeder, G. D., and Landau, S. (1999). A social-psychological analysis of HIV-related stigma: A two-factor theory. American Behavioral Scientist, 42, 1193-1211.
Remien, R. H. (1998). Adhering to HIV combination therapy: The role of the pharmacist. Pharmacy Times, 1998(May), 28-37.
Remien, R. H., and Rabkin, J. G. (2001). Psychological aspects of living with HIV disease: A primary care perspective. Journal of Western Medicine, 175, 332-335.
Remien, R. H., Carballo-Dieguez, A., and Wagner, G. (1995). Intimacy and sexual risk behavior in serodiscordant male couples. AIDS Care, 7, 429-438.
Roberts, K. J. (2000). Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens. AIDS Patient Care and STDs, 14, 155-168.
Roca, B., Gómez, C. J., and Arnedo, A. (1999). Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients: Adherence, side effects and efficacy. Journal of Infection, 39, 141-145.
Roca, B., Gómez, C. J., and Arnedo, A. (2000). Adherence, side effects and efficacy of stavudine plus lamivudine plus nelfinavir in treatment-experienced HIV-infected patients. Journal of Infection, 41, 50-54.
Rodriguez Rosado, R., Jimenez Nacher, I., and Soriano, V. (1998). Virological failure and adherence to antiretroviral therapy in HIV-infected patients. AIDS, 12, 1112-1113.
Sorensen, J. L., Mascovich, A., Wall, T. L., DePhilippis, D., Batki, S. L., and Chesney, M. (1998). Medication adherence strategies for drug abusers with HIV/AIDS. AIDS Care, 10, 297-312.
Strauss, A., and Corbin, J. M. (1998). Basics of qualitative research: Techniques and procedures for developing grounded theory (2nd ed.). Thousand Oaks, CA: Sage.
Wagner, G., Remien, R. H., Carballo-Dieguez, A., and Dolezal, C. (2002). Correlates of adherence to combination antiretroviral therapy among HIV+ members of HIV mixed status couples. AIDS Care, 14, 105-109.
Wahl, L. M., and Nowak, M. A. (2000). Adherence and drug resistance: Predictions for therapy outcome. Proceedings of the Royal Society of London. Series B. Biological Sciences, 267, 835-843.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Remien, R.H., Hirky, A.E., Johnson, M.O. et al. Adherence to Medication Treatment: A Qualitative Study of Facilitators and Barriers Among a Diverse Sample of HIV+ Men and Women in Four U.S. Cities. AIDS Behav 7, 61–72 (2003). https://doi.org/10.1023/A:1022513507669
Issue Date:
DOI: https://doi.org/10.1023/A:1022513507669